FDA Approved: GLEOSTINE — Supplemental Application (NextSource Biotechnology, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Gleostine (lomustine) submitted by NextSource Biotechnology, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma
• Hodgkin Lymphoma
• Oligodendroglioma

Drugs mentioned

• Gleostine (lomustine)

Snippet

SUPPL AP for GLEOSTINE (LOMUSTINE)